Evidence map›Paper›PMID 40835628›Full record

ArticleScientific reports2025

Oncological outcome and survival predictors of widowed patients with bladder cancer in special populations.

Fu-Zhen Sun, Yi-Xuan Liu, Qing-Le Xu, Liu-Xiong Guo, Pan-Ying Zhang, Liang Liu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fu-Zhen SunDepartment of Urology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China. sfz20050122@sina.com.
Yi-Xuan LiuDepartment of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Qing-Le XuDepartment of Urology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China.
Liu-Xiong GuoDepartment of Urology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China.
Pan-Ying ZhangDepartment of Urology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China.
Liang LiuUrology department, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing University, Chongqing, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to identify prognostic indicators and develop a nomogram to predict the overall survival (OS) of widowed bladder cancer (WBCa) patients. WBCa patients between 2004 and 2015 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. The patients were randomly divided into the training and validation sets at a 7:3 ratio. Independent prognostic factors were determined using univariate and multivariate Cox analyses. We constructed a nomogram to predict 3- and 5-year for WBCa patients based on the results of multivariate Cox regression analysis. Consistency index (C-index), receiving operating characteristic (ROC), and calibration curve were used to assess the predictive accuracy of the nomogram. Gender, age at diagnosis, ethnicity, histologic type, histologic grade, tumor‑node metastasis (TNM) stage, and surgery were identified as independent predictors of OS. The C-index value of the nomogram for predicting OS was 0.704 and 0.701 in the training and validation cohorts, respectively. The ROC curves and calibration plots indicated that the model was relatively accurate. Independent prognostic factors for WBCa patients were identified, and a nomogram was constructed to predict the 3- and 5-year OS. The model enables clinicians to determine cancer patients' survival prognosis and formulate personalized treatment plans.

Indexed as

Urinary Bladder NeoplasmsWidowhoodAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingNomogramsPrognosisProportional Hazards ModelsROC CurveSEER ProgramNomogramOverall survivalSEERUrinary bladder neoplasmsWidowed

Identifiers

PMID40835628
PMCPMC12368261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.